APIMEDS PHARMACEUTICALS US, INC. Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate
APIMEDS PHARMACEUTICALS US, INC. (APUS) had Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate of 5.00% as of 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Debt
us-gaap:LongTermDebtPercentageBearingFixedInterestRate · last filed 2025-04-15
- 2024-12-31: Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate 5.00%.
| Period end | Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate |
|---|---|
| 2024-12-31 | 5.00% 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |